Advertisement
Search for

Volume 7, Issue 9, Pages 931-943 (September 2009)


View previous. 20 of 33 View next.

Endoscopic Retrograde Pancreatography

Olga BarkayCorresponding Author Informationemail address, Evan L. Fogel, James L. Watkins, Lee McHenry, Glen A. Lehman, Stuart Sherman

published online 12 June 2009.

Since its introduction in 1968,1 endoscopic retrograde cholangiopancreatography (ERCP) has become an integral part of gastroenterological practice. During ERCP, a side-viewing endoscope is passed through the mouth to the duodenum, the papilla is identified and cannulated, and radiographic contrast material is injected into the bile duct and/or pancreatic duct under fluoroscopic guidance. Like biliary endoscopy, endoscopic retrograde pancreatography (ERP) has evolved from being only a diagnostic procedure to frequently a therapeutic one, providing patients with a minimally invasive method to treat selected pancreatic diseases that previously required open surgery. However, fear of complications, particularly pancreatitis, has prevented some endoscopists from applying techniques used in therapeutic cholangiography for treatment of pancreatic disorders.2 Therefore, ERP with associated therapy is mostly performed in expert centers. In this review, we will focus on the normal and abnormal pancreatic ductal anatomy, indications for ERP, and techniques to optimize the acquisition and interpretation of pancreatographic images. Discussion of pancreatic endotherapy and its complications is beyond the scope of this review.

Division of Gastroenterology and Hepatology, Indiana University Hospital, Indianapolis, Indiana

Corresponding Author InformationReprint requests Address requests for reprints to: Olga Barkay, MD, Indiana University Hospital, 550 North University Boulevard, Suite 4100, Indianapolis, Indiana 46202; fax: (317) 274-3710

 Conflicts of interest The authors disclose no conflicts.

PII: S1542-3565(09)00532-1

doi:10.1016/j.cgh.2009.06.002


View previous. 20 of 33 View next.

Advertisement